Biocardia logo

Biocardia Share Price (NASDAQ: BCDA)

$1.89

0.08

(4.42%)

Last updated on

Check the interactive Biocardia Stock chart to analyse performance

Biocardia stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$1.83
    Today's High:$1.92

    Day's Volatility :4.69%

  • 52 Weeks Low:$1.63
    52 Weeks High:$4.66

    52 Weeks Volatility :65.13%

Biocardia Stock Returns

PeriodBiocardia IncIndex (Russel 2000)
3 Months
-7.25%
0.0%
6 Months
-10.7%
0.0%
1 Year
-22.89%
0.0%
3 Years
-93.76%
-7.8%

Biocardia Inc Key Stats

Check Biocardia key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.81
Open
$1.83
Today's High
$1.92
Today's Low
$1.83
Market Capitalization
$10.5M
Today's Volume
$65.4K
52 Week High
$4.66
52 Week Low
$1.625
Revenue TTM
$0.0
EBITDA
$-8.8M
Earnings Per Share (EPS)
$-1.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-737.89%

Stock Returns calculator for Biocardia Stock including INR - Dollar returns

The Biocardia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biocardia investment value today

Current value as on today

₹80,219

Returns

₹19,781

(-19.78%)

Returns from Biocardia Stock

₹24,096 (-24.1%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Biocardia Stock

-58%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Search interest for Biocardia Stock from India on INDmoney has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Biocardia Inc

  • Name

    Holdings %

  • CM Management, LLC

    2.36%

  • Susquehanna International Group, LLP

    1.09%

  • Geode Capital Management, LLC

    0.67%

  • Brown Advisory Holdings Inc

    0.64%

  • Commonwealth Equity Services Inc

    0.28%

  • Vanguard Group Inc

    0.23%

Analyst Recommendation on Biocardia Stock

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Biocardia(by analysts ranked 0 to 5 stars)

Biocardia Share Price Target

What analysts predicted

Upside of 217.46%

Target:

$6.00

Current:

$1.89

Biocardia share price target is $6.00, a slight Upside of 217.46% compared to current price of $1.89 as per analysts' prediction.

Biocardia Stock Insights

  • Price Movement

    In the last 3 years, BCDA stock has moved down by -93.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 58.0K → -58.0K (in $), with an average decrease of 200.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -2.71M → -2.04M (in $), with an average increase of 32.4% per quarter
  • BCDA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 89.5%
  • BCDA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 109.5% return, outperforming this stock by 203.3%

Biocardia Technicals Summary

Sell

Neutral

Buy

Biocardia is currently in a neutral trading position according to technical analysis indicators.

Biocardia Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Biocardia Inc logo
-16.88%
-10.7%
-22.89%
-93.76%
-94.53%
Regeneron Pharmaceuticals, Inc. logo
4.38%
-17.37%
-50.85%
-2.23%
-0.91%
Beone Medicines Ltd logo
5.81%
21.35%
61.84%
78.01%
32.14%
Vertex Pharmaceuticals Incorporated logo
-16.34%
-17.97%
-17.9%
35.76%
47.74%
Alnylam Pharmaceuticals, Inc. logo
38.5%
82.49%
66.63%
105.56%
244.81%

About Biocardia Inc

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths products. It has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. It also has a development and commercialization agreement with CART-Tech, B.V. for the development of Heart3D Fusion Imaging system. BioCardia, Inc. is based in Sunnyvale, California.
Organization
Biocardia
Employees
17
CEO
Dr. Peter A. Altman Ph.D.
Industry
Biotechnology

Key Management of Biocardia Inc

NameTitle
Dr. Peter A. Altman Ph.D.
CEO, President & Director
Mr. David McClung
Chief Financial Officer
Mr. Edward M. Gillis
Senior Vice President of Devices

Important FAQs about investing in BCDA Stock from India :

What is Biocardia share price today?

Biocardia share price today is $1.89 as on at the close of the market. Biocardia share today touched a day high of $1.92 and a low of $1.83.

What is the 52 week high and 52 week low for Biocardia share?

Biocardia share touched a 52 week high of $4.66 and a 52 week low of $1.63. Biocardia stock price today i.e. is closed at $1.89, lower by 59.44% versus the 52 week high.

How to invest in Biocardia Stock (BCDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biocardia on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biocardia Shares that will get you 0.7937 shares as per Biocardia share price of $1.89 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Biocardia Stock (BCDA) from India?

Indian investors can start investing in Biocardia (BCDA) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Biocardia stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Biocardia share’s latest price of $1.89 as on August 23, 2025 at 1:29 AM IST, you will get 5.2910 shares of Biocardia. Learn more about fractional shares .

What are the returns that Biocardia has given to Indian investors in the last 5 years?

Biocardia stock has given -94.53% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?